Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
07/2000
07/06/2000CA2356838A1 Imidazole compounds and medicinal use thereof
07/06/2000CA2356748A1 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia
07/06/2000CA2356671A1 Protease inhibitors
07/06/2000CA2356638A1 Indole and indolizidine derivatives for the treatment of migraine
07/06/2000CA2356606A1 Method of using a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
07/06/2000CA2356462A1 Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
07/06/2000CA2356459A1 Method of using a matrix metalloproteinase inhibitor and radiation therapy as combination therapy in the treatment of neoplasia
07/06/2000CA2356402A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia
07/06/2000CA2356302A1 Method of using a cyclooxygenase-2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia
07/06/2000CA2356214A1 Heterocyclic amides as inhibitors of factor xa
07/06/2000CA2355744A1 Novel inhibitors of farnesyl-protein transferase
07/05/2000EP1016661A1 2,6-dichloro-4-pyridinemethanol derivatives and agricultural chemicals
07/05/2000EP1015446A1 (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents
07/05/2000EP1015441A1 Process to produce 4-hydroxy-2-oxo-pyrane derivatives useful as protease inhibitors
07/05/2000EP1014962A1 Antithrombotic agents
07/05/2000EP0882138B1 Stereoselective preparation of 2-substituted succinic derivatives
07/05/2000EP0788490B1 Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis
07/05/2000EP0686151B1 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
07/05/2000EP0639180B1 Process for stereospecific hydrolysis of piperidinedione derivatives
07/05/2000EP0630367B1 Novel arylindazoles and their use as herbicides
07/05/2000CN1259122A Method for producing chiral 3,4-dehydroprolines
07/05/2000CN1259049A Carboxamides useful as 5-HT1F agonists
07/05/2000CN1258675A Process and intermediate for producing 5-lipoxidase inhibitor
07/05/2000CN1054129C Process for producing 3-arylbenzofuranone
07/04/2000US6083955 Having a high affinity for drugs, especially endoserine receptors
07/04/2000US6083944 Enzyme inhibitors; treatment of various debilitating disorders
07/04/2000US6083881 Pyrazole derivatives as herbicides
07/04/2000CA2116565C Low speed model following velocity command system for rotary wing aircraft
06/2000
06/29/2000WO2000037473A1 Epothilone derivatives and their use as antitumor agents
06/29/2000WO2000037464A2 4-(aminoalkoxy)benzofurans as n-myristoyltransferase inhibitors
06/29/2000WO2000037463A1 S-oxide lipid lowering compounds
06/29/2000WO2000037462A1 Non-peptide nk1 receptors antagonists
06/29/2000WO2000037461A1 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders
06/29/2000WO2000037458A1 Farnesyl protein transferase inhibitors
06/29/2000WO2000037451A1 Il-5 inhibiting 6-azauracil derivatives
06/29/2000WO2000037436A1 Sulfonamide hydroxamates
06/29/2000WO2000037107A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia
06/29/2000WO2000004893A3 Imidazoline receptor binding compounds
06/29/2000DE19859684A1 Verfahren zur Herstellung von Fluor enthaltenden Phenethylaminen sowie neue, Fluor enthalende beta-Iminovinyl- und beta-Iminoethylbenzole A process for preparing fluorine-containing phenethylamines and new, fluorine enthalende beta-iminovinyl- and beta-iminoethylbenzenes
06/29/2000CA2356426A1 Method of using a cyclooxygenase-2 inhibitor and a matrix metalloproteinase inhibitor as a combination therapy in the treatment of neoplasia
06/29/2000CA2355902A1 Sulfonamide hydroxamates
06/29/2000CA2355822A1 S-oxide lipid lowering compounds
06/29/2000CA2355694A1 Novel bicyclic compounds
06/29/2000CA2355137A1 Non-peptide nk1 receptors antagonists
06/29/2000CA2354511A1 Il-5 inhibiting 6-azauracil derivatives
06/28/2000EP1013649A1 Liquid crystal compounds incorporating furan ring, liquid crystal composition and liquid crystal display device
06/28/2000EP1013637A2 Process for the preparation of fluor containing phenethylamines and fluor containing beta-iminovinyl- and beta-iminoethylphenyl compounds
06/28/2000EP1013276A1 Aminoazacycloalkanes as CCR5 modulators
06/28/2000EP1012166A1 1-amino-7-isoquinoline derivatives as serine protease inhibitors
06/28/2000EP1012147A2 O-substituted hydroxycumaranone derivatives as antitumor and antimetastatic agents
06/28/2000EP1012140A1 New amidino derivatives and their use as thrombin inhibitors
06/28/2000EP1011679A1 Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders
06/28/2000EP1011677A1 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators
06/28/2000EP1011663A1 BETA-LACTAM INHIBITORS OF CoA-IT
06/28/2000CN1258301A Antiviral protease inhibitors
06/28/2000CN1258296A Pyridine derivatives and pharmaceutical compositions contg. them
06/28/2000CN1258291A Polymerisable, optically active dioxolane diesters
06/28/2000CN1258289A Substd. 2-benzoyl-cyclohexane-1,3-diones
06/28/2000CN1258277A Cyanoguanidines as cell proliferation inhibitors
06/28/2000CN1258192A Fungicidal mixtures
06/28/2000CN1257864A Imidazoline compound, preparing process thereof and pharmaceutical composition contg. same
06/28/2000CN1257863A Sterically hindered amine compound
06/28/2000CN1053904C N-pyridyl carboxamides and derivs. processes for their preparation and pharmaceutical compositions contg. them
06/28/2000CN1053903C Dihydrobenzofuran derivs., their production and use
06/27/2000US6080873 Fused pyrrolecarboxamides; a new class of GABA brain receptor ligands
06/27/2000US6080860 Urea compound where one of the urea nitrogens is part of an (un)substituted 5 or 6 membered ring and/or the other urea nitrogen is substituted with a 2-cyano-4,5-dialkoxyphenyl group; reacting with electrophile to form a leaving group
06/27/2000US6080855 2-isocephem and oxacephem derivatives and use as antibacterial agents
06/27/2000US6080775 Plant safening agent; preferably used as fungicide
06/27/2000US6080763 Inhibit the release of inflammatory cytokines, e.g., tumor necrosis factor and interleukin-1; useful to treat chronic inflammatory disease; autoimmune diseases, e.g. rheumatoid arthritis, osteoporosis; pyrazolylureas
06/27/2000US6080759 Paroxetine hydrochloride anhydrate substantially free of bound organic solvent prepared by displacing the solvent with a displacing agent; substantially free of propan-2-ol such that it is other than form z; antidepressants
06/27/2000US6080757 Treatment of helicobacter (campylobacter) pylori infections; treatment and prevention of peptic ulcers, gastritis, dyspepsia, and gastric cancer
06/27/2000US6080750 For prophylaxis and treatment of diseases caused by infection by rotavirus
06/27/2000US6080749 For controlling fungus pests
06/27/2000US6080745 For treating or preventing disorders of dopamine system, such as schizophrenia
06/27/2000US6080743 2,3-dioxo-1,2,3,4-tetrahydro-quinoxalinyl derivatives
06/27/2000CA2188427C Neurotransmitter release enhancers
06/27/2000CA2017193C N-(aryloxyalkyl)heteroarylpiperidines and-heteroarylpiperazines, a pro cess for their preparation and their use as medicaments
06/27/2000CA2013960C Substituted dibenzofurans and methods of using same
06/27/2000CA2011448C 6-amino-6-desoxyfumagillols, production and use thereof
06/27/2000CA2011169C Composition stabilized with substituted 1,2,4-triazoles
06/23/2000CA2292851A1 Process for preparing fluorine-containing phenethylamines and novel fluorine-containing .beta.-iminovinyl-and .beta.-iminoethylbenzenes
06/22/2000WO2000035915A1 Piperazine derivatives
06/22/2000WO2000035911A1 Heteroaryl-cyclic acetals
06/22/2000WO2000035910A1 Derivative of paroxetine
06/22/2000WO2000035909A1 4-aryloxindoles as inhibitors of jnk protein kinases
06/22/2000WO2000035908A1 4-alkenyl (and alkynyl) oxindoles as inhibitors of cyclin-dependent kinases, in particular cdk2
06/22/2000WO2000035907A1 Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
06/22/2000WO2000035906A2 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles
06/22/2000WO2000035901A1 Chroman derivatives
06/22/2000WO2000035886A2 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
06/22/2000WO2000035877A1 Heterocyclic piperidines as modulators of chemokine receptor activity
06/22/2000WO2000035875A1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine urea derivatives having 5ht1a receptor activity
06/22/2000WO2000035873A1 Process for preparation of paroxetine maleate
06/22/2000WO2000035869A1 New amidino derivatives and their use as thrombin inhibitors
06/22/2000WO2000035859A1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines
06/22/2000WO2000035454A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000WO2000035453A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000WO2000035452A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000WO2000035451A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000WO2000035449A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity